Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Syringaresinol protects against diabetic nephropathy by inhibiting pyroptosis via NRF2-mediated antioxidant pathway
Guangru Li, Chang Liu, Lei Yang, et al.
Cell Biology and Toxicology (2023) Vol. 39, Iss. 3, pp. 621-639
Closed Access | Times Cited: 22

Showing 22 citing articles:

The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review
Wencan Li, Xiang Liu, Zheng Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 19
A Review of Medicinal Plants with Renoprotective Activity in Diabetic Nephropathy Animal Models
I Made Wisnu Adhi Putra, Nanang Fakhrudin, Arief Nurrochmad, et al.
Life (2023) Vol. 13, Iss. 2, pp. 560-560
Open Access | Times Cited: 28
Maresin‐1 ameliorates hypertensive vascular remodeling through its receptor LGR6
Zheng Yin, Jishou Zhang, Mengmeng Zhao, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 9
Astragaloside IV Alleviates Doxorubicin-Induced Cardiotoxicity by Inhibiting Cardiomyocyte Pyroptosis through the SIRT1/NLRP3 Pathway
Wencong Tian, P.-Y. Zhang, Lei Yang, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 02, pp. 453-469
Closed Access | Times Cited: 8
Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis
Fugang Huang, Shuo Huang, Ke Sun, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease
Leipengyun Deng, Chunru Shi, Run Li, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118424-118424
Closed Access | Times Cited: 6
ROS induced pyroptosis in inflammatory disease and cancer
Jingsong Wang, Ziyong Wu, Min Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Identification of pyroptosis-related genes and potential drugs in diabetic nephropathy
Meng Yan, Wenwen Li, Rui Wei, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Syringaresinol Alleviates Early Diabetic Retinopathy by Downregulating HIF‐1α/VEGF via Activating Nrf2 Antioxidant Pathway
Chang Liu, Tianwei Cheng, Yufei Wang, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 4
Closed Access | Times Cited: 5
Novel insights into the central protective role of ACE2 in diabetic cardiomyopathy: from underlying signaling pathways to therapeutic perspectives
Xinyi Li, Shunlin Qu
Molecular and Cellular Biochemistry (2025)
Closed Access
Exploring the protective mechanisms of syringaresinol against myocardial infarction by experimental validation and network pharmacology
Lifeng Feng, Ruopeng Sun, Hanmo Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 4, pp. 167728-167728
Closed Access
Effective protective mechanisms of HO-1 in diabetic complications: a narrative review
Jingjing Zhang, Ping Ni, Yi Song, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Metabolomics‐based pharmaceutical evaluation of different parts of Swertia chirayita (Roxb.) Buch.‐Ham. ex C.B. Clarke from the western Himalayas
Devesh Tewari, Sweta Bawari, Saurabh Tarun Mishra, et al.
Journal of Separation Science (2024) Vol. 47, Iss. 1
Closed Access | Times Cited: 1
Exploring the role of NLRP3 inflammasome in diabetic nephropathy and the advancements in herbal therapeutics
Jiangyuan Jin, Mianzhi Zhang
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Diosgenin inhibited podocyte pyroptosis in diabetic kidney disease by regulating the Nrf2/NLRP3 pathway
Yu Tang, WENXIAO HU, YAJUN PENG, et al.
Biocell (2024) Vol. 48, Iss. 10, pp. 1503-1516
Open Access | Times Cited: 1
Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy
Fengzhao Liu, Zhenyu Yang, Jixin Li, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
The Spatiotemporal and Paradoxical Roles of NRF2 in Renal Toxicity and Kidney Diseases
Yiying Bian, Jize Dong, Zhengsheng Zhou, et al.
Redox Biology (2024) Vol. 79, pp. 103476-103476
Open Access | Times Cited: 1
A Comprehensive Review on the Plant Sources, Pharmacological Activities and Pharmacokinetic Characteristics of Syringaresinol
Lei Zhang, Yuqing Tian, Lingling Zhang, et al.
Pharmacological Research (2024), pp. 107572-107572
Open Access | Times Cited: 1
Identification and validation of disulfidptosis-related gene signatures and their subtype in diabetic nephropathy
Danping Xu, Chonghao Jiang, Yonggui Xiao, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
Swollen Feet: Considering the Paradoxical Roles of Interleukins in Nephrotic Syndrome
Maria E. Kovalik, Monique A. Dacanay, Steven D. Crowley, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 738-738
Open Access
Roles of ferroptosis in the development of diabetic nephropathy
Pan Liu, Zhengdong Zhang, Chen Qiu
Journal of Zhejiang University (Medical Sciences) (2024) Vol. 53, Iss. 6, pp. 708-714
Closed Access
The roles of pyroptosis in genitourinary diseases
Haopeng Liu, Haoran Liu, Guoshuai Huang, et al.
International Urology and Nephrology (2023) Vol. 56, Iss. 5, pp. 1515-1523
Open Access
Page 1

Scroll to top